Media Publications - Critical Path Institute

Peter Corr Joins the Critical Path Institute Board of Directors

The Critical Path Institute today announced that Peter B. Corr, Ph.D., has joined its Board of Directors. Dr. Corr has more than 3

The Critical Path Institute (C-Path) and Ventana Medical Systems, Inc. (Ventana) (NASDAQ: VMSI) today released additional informat

The Critical Path Institute (C-Path) announced the receipt of a $4 million grant from the Agency for Healthcare Research and Quali

Thanks to C-Path’s role as an independent, neutral third party, it has been successful in bringing together scientists from

Science Foundation Arizona (SFAz), through its Strategic Research Group (SRG) program, today announced that it is granting nearly

William Mattes of C-Path spoke at the Arizona Pavillion May 8th 2007 about the Predictive Safety Testing Consortium.

To address the issues surrounding a decade-long decrease in the number of new drug approvals, the U.S. Food and Drug Administratio

Developing a new drug is a costly and time-intensive venture. It often takes years to safely develop, test, and ultimately gain Fo

Rosetta Biosoftware announced today that The Critical Path Institute (C-Path) adopted the Rosetta Resolver® system for C-Path&#82

President and CEO of The Critical Path Institute (C-Path) provided testimony and answered questions about drug development yesterd